Anita Shah (A Shah)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Prognostic Factors

Ejection Fraction

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Stephan Schwers, Anita Shah, Camila Linardi, Yang Zhang, Stefan Willmann
Longitudinal observations of TFPI levels in paediatric Haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Alexander Solms, Alfonso Iorio, Maurice J Ahsman, Peter Vis, Anita Shah, Erik Berntorp, Dirk Garmann
Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach. Clinical pharmacokinetics 59 (5) (2021)
Alexander Solms, Shadan Lalezari, Anita Shah, Gili Kenet
Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81-8973 from rFVIII-FS can continue their dosing schedule with improved protection. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Anita Shah, Alexander Solms, Dirk Garmann, Yvonne Katterle, Verzhiniya Avramova, Stanislav Simeonov, Toshko Lissitchkov
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A. Clinical pharmacokinetics 56 (9) (2018)
Anita Shah, T Coyle, S Lalezari, Kathelijn Fischer, B Kohlstaedde, H Delesen, S Radke, L A Michaels
BAY 94-9027, a PEGylated recombinant factor VIII, exhibits a prolonged half-life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies. Haemophilia : the official journal of the World Federation of Hemophilia 24 (5) (2018)